首页 > 最新文献

Dermatology online journal最新文献

英文 中文
Silver sulfadiazine in modern dermatology. 银磺胺嘧啶在现代皮肤病学中的应用。
Q3 Medicine Pub Date : 2025-11-14 DOI: 10.25251/9wwnjf59
Natalia Chalupczak, Jessica Q Duong, Joseph Jorizzo, Steven R Feldman

Silver sulfadiazine, a topical antimicrobial that releases silver ions to disrupt bacterial cell membranes, is primarily used for second- and third-degree burns owing to its broad-spectrum activity against bacteria, fungi, and certain viruses. Beyond burns, silver sulfadiazine can be used off-label for conditions such as diabetic and pressure ulcers, atopic dermatitis, and radiation dermatitis. The literature suggests it may reduce bacterial load, accelerate healing, and address challenges such as multidrug-resistant Staphylococcus aureus. Rare side effects, including localized reactions and systemic toxicity with extensive use, necessitate cautious application, especially in vulnerable populations. Despite these limitations, silver sulfadiazine remains a cornerstone of dermatological wound care. Continued research is needed to optimize its use alongside emerging therapies.

磺胺嘧啶银是一种局部抗菌剂,释放银离子破坏细菌细胞膜,主要用于二度和三度烧伤,因为它对细菌、真菌和某些病毒具有广谱活性。除烧伤外,磺胺嘧啶银还可用于治疗糖尿病、压疮、特应性皮炎和放射性皮炎等病症。文献表明,它可以减少细菌负荷,加速愈合,并解决诸如耐多药金黄色葡萄球菌等挑战。罕见的副作用,包括广泛使用的局部反应和全身毒性,需要谨慎使用,特别是在易感人群中。尽管有这些限制,磺胺嘧啶银仍然是皮肤伤口护理的基石。需要继续研究以优化其与新兴疗法的使用。
{"title":"Silver sulfadiazine in modern dermatology.","authors":"Natalia Chalupczak, Jessica Q Duong, Joseph Jorizzo, Steven R Feldman","doi":"10.25251/9wwnjf59","DOIUrl":"https://doi.org/10.25251/9wwnjf59","url":null,"abstract":"<p><p>Silver sulfadiazine, a topical antimicrobial that releases silver ions to disrupt bacterial cell membranes, is primarily used for second- and third-degree burns owing to its broad-spectrum activity against bacteria, fungi, and certain viruses. Beyond burns, silver sulfadiazine can be used off-label for conditions such as diabetic and pressure ulcers, atopic dermatitis, and radiation dermatitis. The literature suggests it may reduce bacterial load, accelerate healing, and address challenges such as multidrug-resistant Staphylococcus aureus. Rare side effects, including localized reactions and systemic toxicity with extensive use, necessitate cautious application, especially in vulnerable populations. Despite these limitations, silver sulfadiazine remains a cornerstone of dermatological wound care. Continued research is needed to optimize its use alongside emerging therapies.</p>","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"31 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147270030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapidly progressing Kaposi sarcoma in a human immunodeficiency virus-negative patient. 人类免疫缺陷病毒阴性患者快速发展的卡波西肉瘤。
Q3 Medicine Pub Date : 2025-11-14 DOI: 10.25251/qs5e9j71
Phong Thanh Lenh, Nam Hoai Vo, Trung Thanh Hoang

Kaposi sarcoma (KS) is a vascular tumor caused by human herpesvirus-8 (HHV-8), most often associated with human immunodeficiency virus (HIV)-positive individuals. However, KS can also occur in HIV-negative patients, though less commonly. We report a rare case of classic KS in an HIV-negative man with no history of male-to-male sexual activity, who experienced rapid progression to stage IV disease within 3 months. To our knowledge, this is the first documented case of classic KS in Vietnam, highlighting the potential for aggressive KS presentations in immunocompetent Asian individuals. This case underscores the importance of considering KS in the differential diagnosis of rapidly advancing skin lesions, even in patients without traditional risk factors, to ensure timely diagnosis and appropriate management.

卡波西肉瘤(KS)是一种由人类疱疹病毒-8 (HHV-8)引起的血管肿瘤,通常与人类免疫缺陷病毒(HIV)阳性个体有关。然而,KS也可能发生在hiv阴性患者中,尽管不太常见。我们报告一例罕见的经典KS病例,患者为hiv阴性男性,无男性间性行为史,在3个月内迅速发展为IV期疾病。据我们所知,这是越南首例记录在案的经典KS病例,突出了免疫能力强的亚洲个体中侵袭性KS表现的可能性。该病例强调了在快速进展的皮肤病变的鉴别诊断中考虑KS的重要性,即使在没有传统危险因素的患者中,也要确保及时诊断和适当管理。
{"title":"Rapidly progressing Kaposi sarcoma in a human immunodeficiency virus-negative patient.","authors":"Phong Thanh Lenh, Nam Hoai Vo, Trung Thanh Hoang","doi":"10.25251/qs5e9j71","DOIUrl":"https://doi.org/10.25251/qs5e9j71","url":null,"abstract":"<p><p>Kaposi sarcoma (KS) is a vascular tumor caused by human herpesvirus-8 (HHV-8), most often associated with human immunodeficiency virus (HIV)-positive individuals. However, KS can also occur in HIV-negative patients, though less commonly. We report a rare case of classic KS in an HIV-negative man with no history of male-to-male sexual activity, who experienced rapid progression to stage IV disease within 3 months. To our knowledge, this is the first documented case of classic KS in Vietnam, highlighting the potential for aggressive KS presentations in immunocompetent Asian individuals. This case underscores the importance of considering KS in the differential diagnosis of rapidly advancing skin lesions, even in patients without traditional risk factors, to ensure timely diagnosis and appropriate management.</p>","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"31 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147270051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pretibial epidermolysis bullosa: compound heterozygous variants in a rare dystrophic epidermolysis bullosa subtype. 胫骨前大疱性表皮松解症:罕见的营养不良大疱性表皮松解症亚型的复合杂合变异。
Q3 Medicine Pub Date : 2025-11-14 DOI: 10.25251/6s296862
Joana Vieitez-Frade, João Ferreira, Beatriz Tomaz, André Travessa, Pedro Vasconcelos, Luís Soares-de-Almeida, Paulo Filipe

Pretibial epidermolysis bullosa (PEB) is a rare subtype of dystrophic epidermolysis bullosa (DEB), characterized by trauma-induced blistering and scarring limited to the pretibial area. DEB results from monoallelic or biallelic variants in the COL7A1 gene, which encodes type VII collagen. PEB generally presents with milder symptoms than other DEB forms. We report a 50-year-old man with a 30-year history of asymptomatic erythematous patches and tense blisters on the pretibial areas, triggered by construction work and improving during vacations. Physical examination revealed bilateral erythematous plaques, tense bullae, crusted erosions, and nail dystrophy of the feet. Histology and EM showed subepidermal blisters and defects in anchoring fibrils. Genetic testing identified presumptive compound heterozygosity for 2 likely pathogenic COL7A1 variants: a previously reported missense variant (c.151C>G; p.Arg51Gly) and a novel frameshift variant (c.1752del; p.Ser585Valfs*30). Symptomatically management included protective dressings. The specific combination of variants in this patient has not been previously documented. This case underscores the relevance of diagnosing PEB and identifying novel COL7A1 variants, emphasizing the need for further research to understand genotype-phenotype correlations and explore treatment options.

大疱性胫骨前表皮松解症(PEB)是一种罕见的营养不良性大疱性表皮松解症(DEB)亚型,其特征是胫骨前区域的创伤性起泡和瘢痕。DEB是由编码VII型胶原蛋白的COL7A1基因的单等位或双等位变异引起的。与其他DEB形式相比,PEB通常表现出较轻的症状。我们报告一名50岁男性,30年无症状红斑斑块和胫骨前区域紧张水泡的历史,由建筑工作引发,并在假期期间改善。体格检查显示双侧红斑斑块、紧绷大疱、结痂糜烂和足部指甲营养不良。组织学和电镜显示皮下水疱和锚定原纤维缺损。基因检测确定了2种可能致病的COL7A1变异的推定复合杂合性:先前报道的错义变异(c.151C>G; p.Arg51Gly)和一种新的移码变异(c.1752del; p.Ser585Valfs*30)。症状处理包括保护性敷料。该患者的具体变异组合以前没有文献记载。该病例强调了诊断PEB和鉴定新的COL7A1变异的相关性,强调需要进一步研究以了解基因型-表型相关性并探索治疗方案。
{"title":"Pretibial epidermolysis bullosa: compound heterozygous variants in a rare dystrophic epidermolysis bullosa subtype.","authors":"Joana Vieitez-Frade, João Ferreira, Beatriz Tomaz, André Travessa, Pedro Vasconcelos, Luís Soares-de-Almeida, Paulo Filipe","doi":"10.25251/6s296862","DOIUrl":"https://doi.org/10.25251/6s296862","url":null,"abstract":"<p><p>Pretibial epidermolysis bullosa (PEB) is a rare subtype of dystrophic epidermolysis bullosa (DEB), characterized by trauma-induced blistering and scarring limited to the pretibial area. DEB results from monoallelic or biallelic variants in the COL7A1 gene, which encodes type VII collagen. PEB generally presents with milder symptoms than other DEB forms. We report a 50-year-old man with a 30-year history of asymptomatic erythematous patches and tense blisters on the pretibial areas, triggered by construction work and improving during vacations. Physical examination revealed bilateral erythematous plaques, tense bullae, crusted erosions, and nail dystrophy of the feet. Histology and EM showed subepidermal blisters and defects in anchoring fibrils. Genetic testing identified presumptive compound heterozygosity for 2 likely pathogenic COL7A1 variants: a previously reported missense variant (c.151C>G; p.Arg51Gly) and a novel frameshift variant (c.1752del; p.Ser585Valfs*30). Symptomatically management included protective dressings. The specific combination of variants in this patient has not been previously documented. This case underscores the relevance of diagnosing PEB and identifying novel COL7A1 variants, emphasizing the need for further research to understand genotype-phenotype correlations and explore treatment options.</p>","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"31 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147269979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A pediatric case of idiopathic harlequin syndrome. 儿童特发性小丑综合征1例。
Q3 Medicine Pub Date : 2025-11-14 DOI: 10.25251/xs0yzc98
Yasmine Rkiek, Ouiame El Jouari, Salim Gallouj

Harlequin syndrome is a rare condition characterized by asymmetric facial flushing and sweating in reaction to heat, exercise, or emotional circumstances. It results from a defect of the autonomic nervous system. The syndrome can arise from structural defects or iatrogenic factors or can be primary (idiopathic) and have a benign course. We report a 4-year-old boy who experienced sweating and flushing on the left side of the face after exercise. He had no noteworthy medical or birth history. Neurological and ophthalmological examinations revealed no additional abnormalities. Magnetic resonance imaging of the cervicothoracic spinal cord and cerebrum showed no anomalies. A diagnosis of idiopathic harlequin syndrome was made.

丑角综合征是一种罕见的疾病,其特征是在高温、运动或情绪环境下,面部不对称潮红和出汗。它是由自主神经系统的缺陷引起的。该综合征可以由结构缺陷或医源性因素引起,也可以是原发性(特发性)并具有良性病程。我们报告一个4岁的男孩,他在运动后经历了左脸出汗和潮红。他没有值得注意的病史或出生史。神经学和眼科检查未发现其他异常。颈胸脊髓及大脑核磁共振未见异常。诊断为特发性小丑综合征。
{"title":"A pediatric case of idiopathic harlequin syndrome.","authors":"Yasmine Rkiek, Ouiame El Jouari, Salim Gallouj","doi":"10.25251/xs0yzc98","DOIUrl":"https://doi.org/10.25251/xs0yzc98","url":null,"abstract":"<p><p>Harlequin syndrome is a rare condition characterized by asymmetric facial flushing and sweating in reaction to heat, exercise, or emotional circumstances. It results from a defect of the autonomic nervous system. The syndrome can arise from structural defects or iatrogenic factors or can be primary (idiopathic) and have a benign course. We report a 4-year-old boy who experienced sweating and flushing on the left side of the face after exercise. He had no noteworthy medical or birth history. Neurological and ophthalmological examinations revealed no additional abnormalities. Magnetic resonance imaging of the cervicothoracic spinal cord and cerebrum showed no anomalies. A diagnosis of idiopathic harlequin syndrome was made.</p>","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"31 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147269999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
31-Gene expression profiling for cutaneous melanoma: an expert consensus panel. 皮肤黑色素瘤的基因表达谱:专家共识小组。
Q3 Medicine Pub Date : 2025-11-14 DOI: 10.25251/c81v6j23
Joshua Burshtein, Clay Cockerell, David Cotter, Aaron Farberg, Laura Ferris, Mark Kaufmann, Sancy Leachman, Jason Rizzo, Todd Schlesinger, Milaan Shah, Lauren DeBusk, Angela Rosenberg, Brooke Bartley, Mark Lebwohl, Darrell Rigel

Purpose To review published literature on the clinical efficacy, use, and accuracy of the 31-gene expression profiling (31-GEP) test for prognostic information in invasive melanoma. Methods A comprehensive literature search used keywords "31-gene expression profiling," "melanoma," "prognosis," "clinical efficacy," and "clinical utility." A panel of 10 dermatologists with expertise in melanoma management reviewed the articles and created consensus statements. A modified Delphi process approved each statement, requiring supermajority approval through multiple rounds of real-time voting, with strength of recommendation assigned. Results The search produced 150 articles; 26 met inclusion criteria. The panel unanimously voted to adopt 9 consensus statements and recommendations regarding 31-GEP testing: 8 with strength "A" and 1 with strength "C." Conclusion The panel agreed there is strong support for using 31-GEP testing to provide prognostic information for invasive melanoma. The test provides prognostic information when thickness and other traditional factors are unknown, improves prognosis assessment when added to American Joint Committee on Cancer 8th edition staging system, and is associated with improved melanoma-specific mortality and overall survival. The panel concluded that the robust existing literature strongly supports its use as a best practice for appropriate patients with melanoma.

目的回顾31-基因表达谱(31-GEP)检测在侵袭性黑色素瘤预后中的临床疗效、应用和准确性。方法采用关键词“31基因表达谱”、“黑色素瘤”、“预后”、“临床疗效”和“临床效用”进行文献检索。一个由10名在黑色素瘤管理方面具有专业知识的皮肤科医生组成的小组审查了这些文章,并形成了共识声明。经过修改的德尔福程序批准了每个声明,需要通过多轮实时投票获得绝对多数批准,并指定推荐强度。结果检索到150篇文章;26例符合纳入标准。专家组一致投票通过关于31-GEP测试的9项共识声明和建议:8项强度为“A”,1项强度为“c”。专家组一致认为,强烈支持使用31-GEP检测来提供侵袭性黑色素瘤的预后信息。当厚度和其他传统因素未知时,该测试提供预后信息,当加入美国癌症联合委员会第8版分期系统时,该测试可改善预后评估,并与改善黑色素瘤特异性死亡率和总生存率相关。专家组的结论是,现有的大量文献强烈支持将其作为黑色素瘤患者的最佳治疗方法。
{"title":"31-Gene expression profiling for cutaneous melanoma: an expert consensus panel.","authors":"Joshua Burshtein, Clay Cockerell, David Cotter, Aaron Farberg, Laura Ferris, Mark Kaufmann, Sancy Leachman, Jason Rizzo, Todd Schlesinger, Milaan Shah, Lauren DeBusk, Angela Rosenberg, Brooke Bartley, Mark Lebwohl, Darrell Rigel","doi":"10.25251/c81v6j23","DOIUrl":"10.25251/c81v6j23","url":null,"abstract":"<p><p>Purpose To review published literature on the clinical efficacy, use, and accuracy of the 31-gene expression profiling (31-GEP) test for prognostic information in invasive melanoma. Methods A comprehensive literature search used keywords \"31-gene expression profiling,\" \"melanoma,\" \"prognosis,\" \"clinical efficacy,\" and \"clinical utility.\" A panel of 10 dermatologists with expertise in melanoma management reviewed the articles and created consensus statements. A modified Delphi process approved each statement, requiring supermajority approval through multiple rounds of real-time voting, with strength of recommendation assigned. Results The search produced 150 articles; 26 met inclusion criteria. The panel unanimously voted to adopt 9 consensus statements and recommendations regarding 31-GEP testing: 8 with strength \"A\" and 1 with strength \"C.\" Conclusion The panel agreed there is strong support for using 31-GEP testing to provide prognostic information for invasive melanoma. The test provides prognostic information when thickness and other traditional factors are unknown, improves prognosis assessment when added to American Joint Committee on Cancer 8th edition staging system, and is associated with improved melanoma-specific mortality and overall survival. The panel concluded that the robust existing literature strongly supports its use as a best practice for appropriate patients with melanoma.</p>","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"31 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147270039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Generalized bullous fixed drug eruption related to intravenous contrast. 与静脉造影剂相关的全身性大疱性固定药疹。
Q3 Medicine Pub Date : 2025-09-08 DOI: 10.25251/q9brga64
Eliana Figueredo Zamora, Jeffrey P Callen
{"title":"Generalized bullous fixed drug eruption related to intravenous contrast.","authors":"Eliana Figueredo Zamora, Jeffrey P Callen","doi":"10.25251/q9brga64","DOIUrl":"https://doi.org/10.25251/q9brga64","url":null,"abstract":"","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"31 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145421573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sherlock Holmes and the dermatologist. 夏洛克·福尔摩斯和皮肤科医生。
Q3 Medicine Pub Date : 2025-09-08 DOI: 10.25251/yhx10b82
Henry Zou, Marissa Yaldo, Meena Moossavi
{"title":"Sherlock Holmes and the dermatologist.","authors":"Henry Zou, Marissa Yaldo, Meena Moossavi","doi":"10.25251/yhx10b82","DOIUrl":"https://doi.org/10.25251/yhx10b82","url":null,"abstract":"","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"31 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145421615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful treatment of severe acrodermatitis continua of Hallopeau with guselkumab. 格赛单抗成功治疗重度持续性肢端皮炎。
Q3 Medicine Pub Date : 2025-09-08 DOI: 10.25251/dhcdfs98
Neda Cramer, Sara Isik, Michael P Schön, Rotraut Mössner
{"title":"Successful treatment of severe acrodermatitis continua of Hallopeau with guselkumab.","authors":"Neda Cramer, Sara Isik, Michael P Schön, Rotraut Mössner","doi":"10.25251/dhcdfs98","DOIUrl":"https://doi.org/10.25251/dhcdfs98","url":null,"abstract":"","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"31 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145421670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of diffuse Gougerot and Blum purpuric pigmented dermatosis. 弥漫性Gougerot and Blum紫癜性色素皮肤病1例。
Q3 Medicine Pub Date : 2025-09-08 DOI: 10.25251/03wywj65
Alma Poulain, Théo Brochet, Christophe Attencourt, Catherine Lok, Guillaume Chaby

Purpuric and pigmented lichenoid dermatitis of Gougerot and Blum is a form of purpuric pigmented dermatosis. These entities are rarely described, but are likely underdiagnosed. Herein, we present a patient with this condition that is unusual in is its diffuse nature and its delayed diagnosis after twenty years of evolution.

Gougerot and Blum的紫癜性和色素性地衣样皮炎是一种紫癜性色素皮肤病。这些实体很少被描述,但很可能诊断不足。在这里,我们提出了一个病人的这种情况是不寻常的是它的弥漫性和延迟诊断经过二十年的演变。
{"title":"A case of diffuse Gougerot and Blum purpuric pigmented dermatosis.","authors":"Alma Poulain, Théo Brochet, Christophe Attencourt, Catherine Lok, Guillaume Chaby","doi":"10.25251/03wywj65","DOIUrl":"10.25251/03wywj65","url":null,"abstract":"<p><p>Purpuric and pigmented lichenoid dermatitis of Gougerot and Blum is a form of purpuric pigmented dermatosis. These entities are rarely described, but are likely underdiagnosed. Herein, we present a patient with this condition that is unusual in is its diffuse nature and its delayed diagnosis after twenty years of evolution.</p>","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"31 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145421424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of delayed cutaneous S. marcescens after rhinoplasty . 鼻成形术后迟发性皮肤粘质链球菌1例。
Q3 Medicine Pub Date : 2025-09-08 DOI: 10.25251/y574n812
Alice Kesler, Taylor Gray, Christina Sun, Aman Prasad

Serratia marcescens is an uncommon cause of cutaneous infections, especially in immunocompetent individuals. We present a 31-year-old woman with a chronic erythematous nodule on the nasal supratip, three years post-rhinoplasty. Initial treatments, including intralesional corticosteroids, oral doxycycline, and topical metronidazole, failed to resolve the infection. Initially thought to be a contaminant, repeat tissue culture confirmed the presence of S. marcescens. The patient's abscess resolved following a course of levofloxacin but surgery was required to remove remnant scar tissue. This case underscores the importance of considering atypical pathogens in chronic cutaneous infections following cosmetic procedures, even in immunocompetent patients. Increased awareness among clinicians can aid in prompt diagnosis and targeted therapy.

粘质沙雷氏菌是一种罕见的皮肤感染的原因,特别是在免疫能力强的个体。我们提出了一个31岁的妇女,慢性红斑结节在鼻尖上,三年后鼻整形。最初的治疗,包括病灶内皮质类固醇、口服强力霉素和局部甲硝唑,未能解决感染。最初被认为是一种污染物,重复组织培养证实了粘多糖的存在。患者的脓肿在左氧氟沙星疗程后消退,但需要手术切除残余疤痕组织。本病例强调了在美容手术后慢性皮肤感染中考虑非典型病原体的重要性,即使在免疫功能正常的患者中也是如此。提高临床医生的认识有助于及时诊断和靶向治疗。
{"title":"A case of delayed cutaneous <i>S. marcescens </i>after rhinoplasty<b> </b>.","authors":"Alice Kesler, Taylor Gray, Christina Sun, Aman Prasad","doi":"10.25251/y574n812","DOIUrl":"https://doi.org/10.25251/y574n812","url":null,"abstract":"<p><p>Serratia marcescens is an uncommon cause of cutaneous infections, especially in immunocompetent individuals. We present a 31-year-old woman with a chronic erythematous nodule on the nasal supratip, three years post-rhinoplasty. Initial treatments, including intralesional corticosteroids, oral doxycycline, and topical metronidazole, failed to resolve the infection. Initially thought to be a contaminant, repeat tissue culture confirmed the presence of S. marcescens. The patient's abscess resolved following a course of levofloxacin but surgery was required to remove remnant scar tissue. This case underscores the importance of considering atypical pathogens in chronic cutaneous infections following cosmetic procedures, even in immunocompetent patients. Increased awareness among clinicians can aid in prompt diagnosis and targeted therapy.</p>","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"31 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145421504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Dermatology online journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1